Curated from NYT > Health — Here’s what matters right now:
The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
Next step: Want similar protection in your daily life? Explore our anti-surveillance devices designed to detect and deter threats.
Original reporting: NYT > Health